Hameln Pharma Plus Gmbh - Company Review
Hameln Pharma Plus Gmbh - Company ReviewSummary
Hameln Pharma Plus Gmbh (Hameln plus), a subsidiary of hameln group GmbH is a healthcare solution provider that offers pharmaceutical products. The company develops and supplies drug infusion concentrations for use in critical care units. Its products include general anaesthetics, antibacterial drugs, antiemetics, antiinflammatory drugs, bisphosphonates, cardiovascular medicines, muscle relaxants, opioid analgesics, sedative and pre-operative drugs and others. Hameln plus serves doctors, pharmacists and healthcare workers. The company sells its products through a network of distributor in Europe, the Middle East, Asia Pacific, Africa, Central and Latin America, North and South America. Hameln plus is headquartered in Hameln, Germany.
This comprehensive company report of Hameln Pharma Plus Gmbh provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.